文献速递乳腺技术与安全MR

纵向肿瘤体积估算变异对MRI引导乳腺癌新辅助治疗个体化的影响

Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment.
PubMed 文献 · Radiol Imaging Cancer · 2023-01-01

该回顾性分析纳入2010年5月至2016年11月前瞻性I-SPY 2 TRIAL中432例乳腺癌女性,基于自动分割计算功能肿瘤体积(FTV),按视觉评估的FTV低估/高估分为高标准组和标准组,用逻辑回归模型预测病理完全缓解(pCR)。结果显示在∆FTV1、∆FTV2和多预测因子模型中高标准组AUC高于标准组,后两者差异有统计学意义(P=.03和P=.01)。作者认为使用早期FTV变化作为MRI-based乳腺癌治疗个体化标准时需考虑FTV估算的纵向变异。

要点

  • FTV0模型高标准组与标准组AUC相似(0.61 vs 0.62)。
  • ∆FTV1模型高标准组AUC高于标准组(0.74 vs 0.63),差异未达统计学显著。
  • ∆FTV2和多预测因子模型高标准组AUC高于标准组且差异有统计学意义(P=.03和P=.01)。

核心结论

  • 本研究发现提示,使用早期FTV变化作为MRI-based乳腺癌治疗个体化标准时,需考虑FTV估算的纵向变异。

研究设计与样本

  • 回顾性分析,纳入2010年5月至2016年11月前瞻性I-SPY 2 TRIAL中432例乳腺癌女性(平均年龄49.0岁±10.6[SD]),每例在NAC治疗期间接受四次MRI检查,FTV基于自动分割计算。

诊断标准与关键数值

  • FTV0模型高标准组与标准组AUC分别为0.61和0.62。
  • ∆FTV1模型高标准组AUC 0.74 vs 标准组0.63。
  • ∆FTV2模型高标准组AUC 0.79 vs 标准组0.62,差异有统计学意义(P=.03)。
  • 多预测因子模型高标准组AUC 0.85 vs 标准组0.64,差异有统计学意义(P=.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the impact of longitudinal variation in functional tumor volume (FTV) underestimation and overestimation in predicting pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC). Materials and Methods Women with breast cancer who were enrolled in the prospective I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2) from May 2010 to November 2016 were eligible for this retrospective analysis. Participants underwent four MRI examinations during NAC treatment. FTV was calculated based on automated segmentation. Baseline FTV before treatment (FTV0) and the percentage of FTV change at early treatment and inter-regimen time points relative to baseline (∆FTV1 and ∆FTV2, respectively) were classified into high-standard or standard groups based on visual assessment of FTV under- and overestimation. Logistic regression models predicting pCR using single predictors (FTV0, ∆FTV1, and ∆FTV2) and multiple predictors (all three) were developed using bootstrap resampling with out-of-sample data evaluation with the area under the receiver operating characteristic curve (AUC) independently in each group. Results This study included 432 women (mean age, 49.0 years ± 10.6 [SD]). In the FTV0 model, the high-standard and standard groups showed similar AUCs (0.61 vs 0.62). The high-standard group had a higher estimated AUC compared with the standard group in the ∆FTV1 (0.74 vs 0.63), ∆FTV2 (0.79 vs 0.62), and multiple predictor models (0.85 vs 0.64), with a statistically significant difference for the latter two models (P = .03 and P = .01, respectively). Conclusion The findings in this study suggest that longitudinal variation in FTV estimation needs to be considered when using early FTV change as an MRI-based criterion for breast cancer treatment personalization. Keywords: Breast, Cancer, Dynamic Contrast-enhanced, MRI, Tumor Response ClinicalTrials.gov registration no. NCT01042379 Supplemental material is available for this article. © RSNA, 2023 See also the commentary by Ram in this issue.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Onishi N, Bareng TJ, Gibbs J, et al. Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment. Radiol Imaging Cancer. 2023. PMID: 37505107. doi:10.1148/rycan.220126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。